Christopher Porada received his B.S. degree in molecular biology from the Colgate University in 1991 and his Ph.D. degree in cellular and molecular pharmacology and physiology from the University of Nevada in 1998. After completing his Ph.D. degree, he served as an Assistant and then Associate Professor at the Department of Animal Biotechnology, the University of Nevada, Reno, Nev, USA. He has authored over 40 scientific publications and reviews, has written chapters in several books, and has served as an Associate Editor for Experimental Hematology. He is a Member of several international societies including the American Society of Hematology, the International Society of Experimental Hematology, and the American Society of Gene and Cell Therapy. Dr. Porada?s research is broadly focused on the development of safer, more cost-effective treatments that could offer a permanent cure for a variety of genetic disorders. Specifically, he is developing novel gene delivery systems that precisely target individual cell types within the body and is exploring the use of adult stem cells as vehicles for delivering therapeutic genes to specific sites of disease/injury.
Biography Updated on 27 December 2011